Freeline Therapeutics Holdings ADR (NASDAQ:FRLN)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - FRLN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - FRLN

  • Market Cap$545.840m
  • SymbolNASDAQ:FRLN
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS35655L1070

Company Profile

Freeline Therapeutics Holdings PLC is a clinical stage, systemic AAV-based gene therapy company. The company is developing therapies for Haemophilia B, Fabry disease, Gaucher disease, and other diseases.

Latest FRLN news

Currently there for this company. Visit our news hub for other news .